Skip to content
10-Q

Quarterly Report

BIOVIE INC. BIVI BIVIW

0001520138-25-000343

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Nov 7, 2025 7.54M sh
Shares Diluted Q1 2026 · Sep 30, 2025 5.21M sh
Shares Diluted restated Q1 2026 · Sep 30, 2024 639.84K sh
Operating Cash Flow Q1 2026 · Sep 30, 2025 −$3.02M
Operating Cash Flow Q1 2026 · Sep 30, 2024 −$3.58M
Cash And Equivalents Q1 2026 · Sep 30, 2025 $24.98M
Cash And Equivalents Q1 2026 · Jun 30, 2025 $17.54M
Stockholders Equity Q1 2026 · Sep 30, 2025 $24.92M
Stockholders Equity Q1 2026 · Jun 30, 2025 $19.01M
Stockholders Equity Q1 2026 · Sep 30, 2024 $14.07M
Stockholders Equity Q1 2026 · Jun 30, 2024 $15.51M
Current Liabilities Q1 2026 · Sep 30, 2025 $1.64M
Current Liabilities Q1 2026 · Jun 30, 2025 $2.27M
Total Liabilities Q1 2026 · Sep 30, 2025 $1.9M
Total Liabilities Q1 2026 · Jun 30, 2025 $2.55M
Current Assets Q1 2026 · Sep 30, 2025 $26.03M
Current Assets Q1 2026 · Jun 30, 2025 $20.7M
Total Assets Q1 2026 · Sep 30, 2025 $26.82M
Total Assets Q1 2026 · Jun 30, 2025 $21.56M
Eps Diluted Q1 2026 · Sep 30, 2025 −$0.98
Eps Diluted restated Q1 2026 · Sep 30, 2024 −$7.00
Eps Basic Q1 2026 · Sep 30, 2025 −$0.98
Eps Basic restated Q1 2026 · Sep 30, 2024 −$7.00
Sga Expense Q1 2026 · Sep 30, 2025 $2.29M
Sga Expense Q1 2026 · Sep 30, 2024 $2.07M
Rd Expense Q1 2026 · Sep 30, 2025 $2.94M
Rd Expense Q1 2026 · Sep 30, 2024 $1.99M
Net Income Q1 2026 · Sep 30, 2025 −$5.09M
Net Income Q1 2026 · Sep 30, 2024 −$4.15M
Operating Income Q1 2026 · Sep 30, 2025 −$5.28M
Operating Income Q1 2026 · Sep 30, 2024 −$4.12M